Precision BioSciences Inc (DTIL)
1.76
+0.17 (+10.69%)
USD |
NASDAQ |
May 16, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Shareholders Equity (Quarterly): 69.66M for March 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 69.66M |
| December 31, 2021 | 91.17M |
| September 30, 2021 | 101.44M |
| June 30, 2021 | 100.55M |
| March 31, 2021 | 58.82M |
| December 31, 2020 | 44.42M |
| September 30, 2020 | 63.82M |
| Date | Value |
|---|---|
| June 30, 2020 | 85.60M |
| March 31, 2020 | 115.03M |
| December 31, 2019 | 138.31M |
| September 30, 2019 | 155.79M |
| June 30, 2019 | 173.98M |
| March 31, 2019 | 10.83M |
| December 31, 2018 | 39.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.83M
Minimum
Mar 2019
173.98M
Maximum
Jun 2019
89.24M
Average
88.38M
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna Inc | 17.08B |
| Amicus Therapeutics Inc | 238.62M |
| Madrigal Pharmaceuticals Inc | 145.74M |
| Verastem Inc | 72.77M |
| Syros Pharmaceuticals Inc | 85.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 181.35M |
| Total Liabilities (Quarterly) | 111.69M |
| Debt to Equity Ratio | 0.0356 |
| Current Ratio | 4.606 |
| Net Debt Paydown Yield | -0.26% |